Document is current

Article History

Received: 22 July 2025

Accepted: 11 February 2026

First Online: 2 April 2026

Declarations

:

: Human biopsy procedure including the cell culture protocol was approved by the local committee on Research Involving Human Subjects (METC Oost-Nederland; Commissie Mensgebonden Onderzoek (CMO) 2016–2451, NL57509.091.16), entitled “Development of an autologous myogenic cell therapy against the neuromuscular phenotype of myotonic dystrophy type 1”, approval date 18th of October 2016 [ ]. This study is in compliance with the Helsinki Declaration. Informed consent to participate in our study was obtained from all participants. No adverse events following the biopsy procedure were reported. Animal experimental protocol approval was given by the Animal Ethics Committee of Radboud University (Permit numbers RU-DEC 2016-0049, AVD103002016801; RU-DEC 2022-007, AVD10300202216479).

: Not applicable.

: The authors declare no competing interests.